LBT Innovations Limited released its earnings results on Feb 22, 2024. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.

Q: Is LBT Innovations Limited overvalued?

According to Wall Street analysts LBT Innovations Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does LBT Innovations Limited have?

LBT Innovations Limited has 1,339,716,400 shares outstanding.

Q: What happened to LBT Innovations Limited’s price movement after its last earnings report?

LBT Innovations Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

1 Followers

LBT Stock Chart & Stats

Advanced Chart >

Day’s RangeAU$0 - AU$0

52-Week Range<AU$0.01 - AU$0.04

Previous CloseAU$0.02

Volume509.87K

Average Volume (3M)5.48M

Market Cap

AU$26.75M

Enterprise ValueAU$28.25M

Total Cash (Recent Filing)AU$2.79M

Total Debt (Recent Filing)AU$4.29M

Price to Earnings (P/E)-0.4

Beta-0.57

Next Earnings

Aug 29, 2024

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.04

Shares OutstandingN/A

10 Day Avg. Volume427,693

30 Day Avg. Volume5,483,501

Standard Deviation0.34

R-Squared0.00230

Alpha0.03

Financial Highlights & Ratios

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

LBT Innovations Limited News

PremiumCompany Announcements

LBT Innovations Applies for Share Quotation

9d ago

LBT

PremiumCompany Announcements

LBT Innovations Seeks Quotation for New Shares

22d ago

LBT

See More AU:LBT News >

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

9.81% Insiders

0.00% Mutual Funds

0.00% Other Institutional Investors

90.19% Public Companies and

Individual Investors

Detailed Ownership Overview >

LBT FAQ

What was LBT Innovations Limited’s price range in the past 12 months?

LBT Innovations Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.

What is LBT Innovations Limited’s market cap?

Currently, no data Available

When is LBT Innovations Limited’s upcoming earnings report date?

LBT Innovations Limited’s upcoming earnings report date is Aug 29, 2024 which is in 124 days.

How were LBT Innovations Limited’s earnings last quarter?

LBT Innovations Limited released its earnings results on Feb 22, 2024. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.

Is LBT Innovations Limited overvalued?

According to Wall Street analysts LBT Innovations Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does LBT Innovations Limited pay dividends?

LBT Innovations Limited does not currently pay dividends.

What is LBT Innovations Limited’s EPS estimate?

LBT Innovations Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does LBT Innovations Limited have?

LBT Innovations Limited has 1,339,716,400 shares outstanding.

What happened to LBT Innovations Limited’s price movement after its last earnings report?

LBT Innovations Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of LBT Innovations Limited?

Currently, no hedge funds are holding shares in AU:LBT

---

LBT Innovations Limited Stock Smart Score

Neutral

Fundamentals

Return on Equity

-197.95%

Trailing 12-Months

Asset Growth

-71.75%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

LBT Innovations Limited

LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

---